Kurtuluş AKSU, Muhammet Ali BEYOĞLU, Murat YILDIZ, Mehmet Furkan ŞAHİN

COVID-19 PANDEMİSİ SÜRECİNDE SON DÖNEM AKCİĞER HASTALIĞI OLAN BİREYLERDE KAYGININ DEĞERLENDİRİLMESİ

Amaç: COVID-19 salgını sırasında son dönem akciğer hastalığı olan bireylerin kaygı düzeylerinin belirlenmesi amaçlanmıştır. Materyal ve Metot: Çalışmaya altta yatan akciğer hastalığı nedeni ile solunum yetmezliği olan ve uzun süreli oksijen tedavisi kullanan erişkinler dahil edildi. Katılımcılarda durumluk ve sürekli kaygı düzeyleri sırası ile STAI-1 ve STAI-2 skorlarına göre belirlendi Bulgular: STAI-1 değerlendirmesine göre olguların 64’ünde (28,57%) hafif, 142’sinde (63,39%) orta, 18’inde (8,03%) ağır düzeyde anksiyete, STAI-2 değerlendirmesine göre 44’ünde (19,64%) hafif, 164’sinde (73,21%) orta, 16’inde (7,14%) ağır düzeyde anksiyete mevcuttu. STAI-2 değerlendirmesine göre kadınlarda (medyan; min-max: 50; 38-67) erkeklere (42; 26-75) göre kaygı düzeyi daha yüksekti (p

EVALUATION OF ANXIETY IN INDIVIDUALS WITH ENDSTAGE LUNG DISEASE DURING COVID-19 PANDEMIC

Objectives: With this study, it was aimed to determine the anxiety levels of individuals with end-stage lung disease during the COVID-19 outbreak. Materials and Methods: Adults with respiratory failure due to underlying lung disease and using long-term oxygen therapy were included in the study. State and trait anxiety levels of the participants were determined according to the STAI-1 and STAI-2 scores. Results: According to the STAI-1 evaluation, 64 (28,57) of the cases had mild, 142 (63,39) moderate, and 18 (8,03) severe anxiety, and according to the STAI-2 evaluation, 44 (19,64) had mild, 164 (73,21) moderate, and 16 (7.14) had severe anxiety. According to the STAI-2 evaluation, the anxiety level was statistically significantly higher in women (median; min-max: 50; 38-67) compared to men (42; 26-75) (p

PDF

___

1. Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206.
2. Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524.
3. Aksu K, Naziroğlu T, Özkan P. Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination. Clin Exp Immunol. 2020;202(2):220-5.
4. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763-70.
5. Bavel JJV, Baicker K, Boggio PS, et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020;4(5):460-71.
6. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;89:531-42.
7. Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental health consequences and target populations. Psychiatry Clin Neurosci. 2020;74(4):281-2.
8. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912-20.
9. Tahmassian K, Jalali Moghadam N. Relationship between self-efficacy and symptoms of anxiety, depression, worry and social avoidance in a normal sample of students. Iran J Psychiatry Behav Sci. 2011;5(2):91-8.
10. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs L. vol. 22. Calif Consulting Psychologists Press; 1970. pp. 1–24. (Manual for the State-Trait. Anxiety Inventory Palo Alto).
11. Öner N, Le Compte A. (1998). Süreksiz Durumluk/Sürekli Kaygı Evanteri El Kitabı.(2.Basım). İstanbul: Boğaziçi Üniversitesi Yayınevi.
12. Global Strategy for Diagnosis, Management, and Prevention of COPD 2021 report [İnternet] https://goldcopd.org/2021-gold-reports/ (Erişim tarihi 27.04.2021).
13. Sharma BB, Singh S, Sharma VK, et al. Psychiatric morbidity in chronic respiratory disorders in an Indian service using GMHAT/PC. Gen Hosp Psychiatry. 2013;35(1):39-44.
14. Yiğit R, Dilmaç B, Deniz ME, Hamarta E. Sürücülerin Sürekli ve Durumluk Kaygılarının Bazı Değişkenler Açısından İncelenmesi. Uluslararası Avrasya Sosyal Bilimler Dergisi. 2011; 2(4):37-44.
15. Savas E, Tanriverdi D. Knowledge, attitudes and anxiety towards influenza A/H1N1 vaccination of healthcare workers in Turkey. BMC Infect Dis. 2010;10:281.
16. Lee AM, Wong JG, McAlonan GM, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry. 2007;52(4):233-40.
17. Mak IW, Chu CM, Pan PC, Yiu MG, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31(4):318-26.
18. Wang C, Pan R, Wan X, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020;17(5):1729.
19. Islam MS, Ferdous MZ, Potenza MN. Panic and generalized anxiety during the COVID-19 pandemic among Bangladeshi people: An online pilot survey early in the outbreak. J Affect Disord. 20201;276:30-37.
20. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278-85.
21. Felker B, Katon W, Hedrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001;23(2):56-61.
22. Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615-31.
23. Hegerl U, Mergl R. Depression and suicidality in COPD: understandable reaction or independent disorders? Eur Respir J. 2014;44(3):734-43.
24. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S-56S.
25. Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615-31.
26. Lacwik P, Szydłowska D, Kupczyk M, Pałczyński C, Kuna P. High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma. J Allergy Clin Immunol Pract. 2021;9(3):1381-3.
27. Zheng L, Miao M, Lim J, Li M, Nie S, Zhang X. Is Lockdown Bad for Social Anxiety in COVID-19 Regions?: A National Study in The SOR Perspective. Int J Environ Res Public Health. 2020;17(12):4561.
28. Leung GM, Lam TH, Ho LM, et al. The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong. J Epidemiol Community Health. 2003;57(11):857-63.
29. Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr. 2020;51:102083.
30. Jorm AF. Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span. Psychological Medicine. 2000;30(1):11-22.